Zhejiang Bamboo Pharmaceuticals

Zhejiang Bamboo Pharmaceuticals Co., Ltd. is a Chinese pharmaceutical company established in 2020, specializing in the development and manufacture of high-grade Active Pharmaceutical Ingredients (APIs), intermediates, and oral solid formulations. Headquartered in the Hangzhou Bay Economic and Technological Development Zone in Shaoxing, Zhejiang, the company operates a large-scale, modern facility designed to meet international regulatory standards including US FDA, EU GMP, and cGMP. Their product portfolio includes widely used small molecules such as Gabapentin, Pregabalin, Benzocaine, and Tranexamic acid, as well as specialized treatments for erectile dysfunction and gastrointestinal disorders. In addition to its own product line, the company provides Contract Manufacturing Organization (CMO) services and produces food additives like dimethyl dicarbonate. Zhejiang Bamboo Pharmaceuticals emphasizes "green" chemistry and sustainable production practices across its eight chemical synthesis workshops. The company targets a global market, holding certifications and filings in major regions including the United States and Europe.